Non-Motor Symptoms and Health-Related Quality of Life in Patients with Isolated Dystonia: A Cross-Sectional Study
<b>Background/Objectives:</b> Dystonia, traditionally regarded as a purely motor disorder, is now increasingly recognized as involving clinically significant non-motor symptoms (NMSs) that can adversely affect patients' health-related quality of life (HRQoL). This study aimed to assess HRQoL in Romanian patients with isolated dystonia and to evaluate the impact of two key NMSs, depression and cognitive impairment, on their HRQoL. We hypothesized that depression would have a greater adverse effect on HRQoL than cognitive impairment. <b>Methods</b>: A cross-sectional study was conducted involving 65 adult Romanian patients with isolated dystonia. HRQoL was measured using the Short Form-36 Health Survey (SF-36), including the physical component summary (PCS) and mental component summary (MCS). Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9), and cognitive impairment was assessed using the Montreal Cognitive Assessment (MoCA). Descriptive statistics, correlation analysis, and parametric and non-parametric tests were used. Multiple regression analysis was employed to evaluate associations between NMS and HRQoL. <b>Results</b>: The mean (SD) age was 56.6 (14.3) years, and 80% of participants were female. Depression and cognitive function were significantly associated with PCS (0.33 and -0.51, respectively) and MCS (0.26 and -0.78, respectively). Multiple regression analysis showed that the two NMS explained 38% of the variance in PCS and 58% of the variance in MCS. Depression had a greater impact on PCS and MCS than cognitive impairment (-0.47 vs. 0.33 and -0.72 vs. 0.16, respectively). Cognitive impairment (MoCA < 26) was present in 35.4% of patients, while 46.2% had at least mild depressive symptoms (PHQ-9 ≥ 5); 23.1% met criteria for moderate-to-severe depression (PHQ-9 ≥ 10). Depressive symptoms showed strong negative correlations with all SF-36 domains, while cognitive performance correlated modestly. <b>Conclusions:</b> Both depression and cognitive impairment have a significant negative impact on HRQoL in dystonia, with depression having a stronger effect, as we hypothesized. Routine screening for non-motor symptoms is essential to support better clinical outcomes and enhance patients' quality of life.
Authors
- Alexandru Balog (ORCID: https://orcid.org/0000-0003-4603-3951)
- Alexandru Constantinescu (ORCID: https://orcid.org/0009-0007-1162-5777)
- Cătălina Raluca Nuță (ORCID: https://orcid.org/0000-0002-4899-1662)
- Lidia Bãjenaru (ORCID: https://orcid.org/0000-0002-1800-3897)
- Ovidiu Lucian Băjenaru
- Octavian Andronic (ORCID: https://orcid.org/0000-0002-9053-0018)
Institutions
- Carol Davila University of Medicine and Pharmacy (RO)
- Clinical Emergency Hospital Bucharest (RO)
- Emergency University (US)
- National Institute for Research and Development in Informatics - ICI Bucharest (RO)
- Universitatea Națională de Știință și Tehnologie Politehnica București (RO)
- Bucharest University of Economic Studies (RO)
Publication Details
- Journal
- Healthcare
- Published
- 2025-07-26
- DOI
- https://doi.org/10.3390/healthcare13151824
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00